Allena Pharmaceuticals Warns of Imminent Funding Need
Zydus receives final approval from the USFDA for Prochlorperazine Maleate
As the Chinese government pilots a bulk procurement program for generic drugs, Big Pharma's older medicines are under increasing pricing pressure. Pfizer is planning a push into China's rural areas in response to the headwinds, and it has moved the headquarters of its Upjohn established medicines business to Shanghai. China's Hansoh Pharma plans to raise $1 billion in a Hong Kong IPO and has secured some venture capital bigwigs as cornerstone investors. And more
The UK Competition and Markets Authority (CMA) has accused Alliance Pharmaceuticals, Focus, Lexon and Medreich of avoiding competition for anti-nausea drug, prochlorperazine.
Four pharmaceutical firms have been accused of illegally colluding to restrict the supply of anti-nausea medication Prochlorperazine after the price of the drug increased by 700%.
Four pharma companies stand accused in the UK of colluding to artificially inflate the price of prescription-only, anti-nausea and dizziness drug prochlorperazine, costing the NHS millions of pounds and breaking competition law.
Nexus Pharmaceuticals announced today it has received U.S. Food and Drug Administration (FDA) approval for Prochlorperazine Edisylate Injection, USP in 10mg/2mL vial.
Sanofi-Aventis Australia Recalling One Batch of Stemetil (prochlorperazine maleate) 5 mg Tablets
A Roche spokesperson said today that after receiving evidence of the supply chain breach last week it immediately reported the problem to Australia’s Therapeutics Goods Administration which issued a recall for the Valium. So far there have been no reports of adverse reactions.